129 related articles for article (PubMed ID: 19936177)
1. Incidence of histological prostatitis and its correlation with PSA density.
Piovesan AC; Freire Gde C; Torricelli FC; Cordeiro P; Yamada R; Srougi M
Clinics (Sao Paulo); 2009; 64(11):1049-51. PubMed ID: 19936177
[TBL] [Abstract][Full Text] [Related]
2. Percent of free serum prostate-specific antigen and histological findings in patients undergoing open prostatectomy for benign prostatic hyperplasia.
Scattoni V; Raber M; Montorsi F; Da Pozzo L; Brausi M; Calori G; Freschi M; Rigatti P
Eur Urol; 1999 Dec; 36(6):621-30. PubMed ID: 10559617
[TBL] [Abstract][Full Text] [Related]
3. [Correlation of histological prostatitis with PSA, prostate volume, PSAD, IPSS, Qmax and PVR in BPH patients].
Zhang HT; Xu Y; Chang JW; Zhang ZH; Liu RL; Ma BJ
Zhonghua Nan Ke Xue; 2012 Mar; 18(3):208-11. PubMed ID: 22474983
[TBL] [Abstract][Full Text] [Related]
4. Prostate-specific antigen density: correlation with histological diagnosis of prostate cancer, benign prostatic hyperplasia and prostatitis.
van Iersel MP; Witjes WP; de la Rosette JJ; Oosterhof GO
Br J Urol; 1995 Jul; 76(1):47-53. PubMed ID: 7544204
[TBL] [Abstract][Full Text] [Related]
5. Asymptomatic inflammation and/or infection in benign prostatic hyperplasia.
Nickel JC; Downey J; Young I; Boag S
BJU Int; 1999 Dec; 84(9):976-81. PubMed ID: 10571623
[TBL] [Abstract][Full Text] [Related]
6. Incidence of histological prostatitis and its correlation with PSA density.
Kaplan SA
J Urol; 2011 May; 185(5):1819. PubMed ID: 22088724
[No Abstract] [Full Text] [Related]
7. Serum-to-urinary prostate-specific antigen ratio: a potential means of distinguishing benign prostatic hyperplasia from prostate cancer.
Irani J; Millet C; Levillain P; Doré B; Begon F; Aubert J
Eur Urol; 1996; 29(4):407-12. PubMed ID: 8791046
[TBL] [Abstract][Full Text] [Related]
8. Relationship between serum prostate specific antigen and histological prostatitis in patients with benign prostatic hyperplasia.
Hasui Y; Marutsuka K; Asada Y; Ide H; Nishi S; Osada Y
Prostate; 1994 Aug; 25(2):91-6. PubMed ID: 7518599
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of histological prostatitis in men with benign prostatic hyperplasia or adenocarcinoma of the prostate presenting without urinary retention.
Edlin RS; Heyns CF; Van Vuuren SP; Zarrabi AD
S Afr J Surg; 2012 Nov; 50(4):127-30. PubMed ID: 23217554
[TBL] [Abstract][Full Text] [Related]
10. Effect of chronic prostatitis on angiogenic activity and serum prostate specific antigen level in benign prostatic hyperplasia.
Koseoglu RD; Erdemir F; Parlaktas BS; Filiz NO; Uluocak N; Etikan I
Kaohsiung J Med Sci; 2007 Aug; 23(8):387-94. PubMed ID: 17666305
[TBL] [Abstract][Full Text] [Related]
11. Increased prostate-specific antigen in subclinical prostatitis: the role of aggressiveness and extension of inflammation.
Yaman O; Göğüş C; Tulunay O; Tokatli Z; Ozden E
Urol Int; 2003; 71(2):160-4. PubMed ID: 12890953
[TBL] [Abstract][Full Text] [Related]
12. Correlation of prostate-specific antigen and prostate-specific antigen density with outcome of prostate biopsy.
Bare R; Hart L; McCullough DL
Urology; 1994 Feb; 43(2):191-6. PubMed ID: 7509526
[TBL] [Abstract][Full Text] [Related]
13. Inflammation in prostate biopsies of men without prostatic malignancy or clinical prostatitis: correlation with total serum PSA and PSA density.
Schatteman PH; Hoekx L; Wyndaele JJ; Jeuris W; Van Marck E
Eur Urol; 2000 Apr; 37(4):404-12. PubMed ID: 10765070
[TBL] [Abstract][Full Text] [Related]
14. The correlation between serum prostate specific antigen levels and asymptomatic inflammatory prostatitis.
Ozden C; Ozdal OL; Guzel O; Han O; Seckin S; Memis A
Int Urol Nephrol; 2007; 39(3):859-63. PubMed ID: 17111077
[TBL] [Abstract][Full Text] [Related]
15. Inflammation in benign prostatic hyperplasia: correlation with prostate specific antigen value.
Irani J; Levillain P; Goujon JM; Bon D; Doré B; Aubert J
J Urol; 1997 Apr; 157(4):1301-3. PubMed ID: 9120926
[TBL] [Abstract][Full Text] [Related]
16. The histological prevalence of prostatitis at Potchefstroom Hospital: a cross-sectional study.
Prince Kasongo M; Philippa E; Fabienne WH; Marylyne Y; Behnazir M
Pan Afr Med J; 2024; 47():8. PubMed ID: 38371643
[TBL] [Abstract][Full Text] [Related]
17. Significance of histological prostatitis in patients with urinary retention and underlying benign prostatic hyperplasia or adenocarcinoma of the prostate.
van Vuuren SP; Heyns CF; Zarrabi AD
BJU Int; 2012 Apr; 109(8):1194-7. PubMed ID: 21851551
[TBL] [Abstract][Full Text] [Related]
18. High serum prostate-specific antigen levels in the absence of prostate cancer in Middle-Eastern men: the clinician's dilemma.
Kehinde EO; Sheikh M; Mojimoniyi OA; Francis I; Anim JT; Nkansa-Dwamena D; Al-Awadi KA
BJU Int; 2003 May; 91(7):618-22. PubMed ID: 12699471
[TBL] [Abstract][Full Text] [Related]
19. Detection of prostate cancer and changes in prostate-specific antigen (PSA) six months after surgery for benign prostatic hyperplasia in patients with elevated PSA.
Ozden C; Inal G; Adsan O; Yazici S; Ozturk B; Cetinkaya M
Urol Int; 2003; 71(2):150-3. PubMed ID: 12890951
[TBL] [Abstract][Full Text] [Related]
20. Association between asymptomatic inflammatory prostatitis NIH category IV and prostatic calcification in patients with obstructive benign prostatic hyperplasia.
Engelhardt PF; Seklehner S; Brustmann H; Riedl CR; Lusuardi L
Minerva Urol Nefrol; 2016 Jun; 68(3):242-9. PubMed ID: 26013949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
